Malaria News and Research

Latest Malaria News and Research

Heartworm medication Ivermectin prevents malaria transmission in Africa

A cheap, common heartworm medication that is already being used to fight other parasites in Africa could also dramatically interrupt transmission of malaria, potentially providing an inexpensive tool to fight a disease that kills almost 800,000 people each year, according to a new study published in the July edition of the American Journal of Tropical Medicine and Hygiene.

7 Jul 2011

Vouchers and Health Equity Funds work well for poor: Research

In rich countries, the government can fund the health system directly, or subsidise the health costs of its inhabitants through the social security system. People then only pay a small lump sum. But in low and mid-income countries, the government doesn't have the money for (almost) free healthcare.

7 Jul 2011

Malaria-carrying mosquitoes becoming increasingly resistant to pyrethroid insecticides

Mosquitoes that carry malaria are increasingly becoming resistant to pyrethroid insecticides, which are the only insecticides approved by the WHO to treat bed nets and are the most effective and cost efficient for indoor spraying, Nature News reports.

7 Jul 2011

Gates Foundation releases interactive malaria infographic

The Bill & Melinda Gates Foundation has released a new infographic "to raise awareness about its campaign to end malaria," Mashable reports.

7 Jul 2011

Review identifies RDTs as effective tool to fight malaria

"A new Cochrane Systematic Review examines the accuracy of Rapid Diagnostic Tests (RDTs), which are designed to detect malaria based on the presence of parasite antigens, using a quick and easy to use format," according to a press release issued by Wiley.

7 Jul 2011

Germany to restore half of Global Fund donation withheld earlier this year

"Germany is unblocking half of the funding it withheld from" the Global Fund to Fight AIDS, Tuberculosis and Malaria "following revelations of corruption earlier this year," the Associated Press reports.

6 Jul 2011

New GHI research examines conflicts between donor and recipient countries

In the early 2000s, the international aid community started to fund health programs through Global Health Initiatives (GHIs) which provide aid and support for tackling infectious diseases, and for implementing immunization programs against childhood diseases. However priorities set by GHIs and by governments are not always the same.

4 Jul 2011

Aquatain surface layer helps control malaria mosquitoes in rice-agro ecosystems

A thin, liquid layer applied on the surface of inundated rice paddies effectively kills malaria mosquito larvae without having an impact on other aquatic life. Rice yield remains the same and water was saved because of the anti-evaporative properties of the layer.

2 Jul 2011

Checklist to stay healthy and active in summer

The summer is a great season for getting in shape. Whether by playing a sport, doing an aerobic exercise routine, or just returning to that familiar running path -- this is the time for activity.

2 Jul 2011

Senate resolution supporting World Malaria Day

The Senate on Monday night unanimously passed the Senate World Malaria Day Resolution, S. Con. Res. 15, a concurrent resolution with the House of Representatives, according to a post on the Malaria Policy Center blog.

30 Jun 2011

Improving health vital to good governance in Nigeria

In a Daily Independent opinion piece, U.S. Ambassador to Nigeria Terence McCulley writes that after "truly historic" elections in April, "the Nigerian Government faces complex challenges in the post-election environment. Security, electricity, good roads, education and reliable health care top most people's lists of immediate concerns."

30 Jun 2011

Global malaria R&D funding has received sustained growth, report says

"Annual funding for research and development (R&D) in the fight against malaria has quadrupled over 16 years, generating the strongest pipeline of potential treatments in history, according to a report on Tuesday," Reuters reports.

30 Jun 2011

Georgia residents strongly support investment in public and global health research

Nearly three-quarters (74%) of Georgia residents think spending money on research to improve health globally is important for economic development in Georgia, according to a new statewide poll commissioned by Research!America.

30 Jun 2011

Global Fund reports mid-year results

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday announced that programs it supports have distributed 190 million insecticide-treated bed nets to protect families from malaria since 2003, according to mid-year results, a Global Fund press release notes.

30 Jun 2011

Vaccines may be given in food in the near future

Soon children could be vaccinated with bacteria mixed in milk and people in the developing world given unprecedented access to immunisations under a scheme proposed by an Australian Nobel laureate, Barry Marshall.

29 Jun 2011

Acetylon to advance ACY-1215 drug candidate with $27M Series B Preferred equity investment round of financing

Acetylon Pharmaceuticals, Inc. announced today that it has completed a $27 million Series B Preferred equity investment round of financing.

29 Jun 2011

France 24's Health program examines challenges to fighting malaria in Madagascar

France 24's video program Health examines challenges to fighting malaria in Madagascar, where some people who cannot afford newer artemisinin-based combination therapies use older, less-effective medications that can promote drug resistance and others misuse mosquito nets.

29 Jun 2011

Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical studies for combating sleeping sickness

Anacor Pharmaceuticals, the Drugs for Neglected Diseases initiative (DNDi), and SCYNEXIS Inc. today announced the successful completion of pre-clinical studies for the first new oral drug candidate discovered specifically to combat human African trypanosomiasis (HAT), also known as sleeping sickness.

29 Jun 2011

Prototype small molecule drugs could suppress hepatitis C

Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK.

29 Jun 2011

Bristol-Myers Squibb and Mylan expand access to HIV drug Reyataz in sub-Saharan Africa and India

Bristol-Myers Squibb Company today announced a new agreement to expand access to Reyataz (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories Limited, a Mylan Company, enables the generic company to manufacture and sell atazanavir, as well as stavudine and didanosine, in sub-Saharan Africa and India.

29 Jun 2011